NAYA Biosciences, Financials
| NAYA Stock | 0.37 0.03 7.50% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | 0.14 |
|
|
The essential information of the day-to-day investment outlook for NAYA Biosciences, includes many different criteria found on its balance sheet. An individual investor should monitor NAYA Biosciences,'s cash flow, debt, and profitability to accurately make informed decisions on whether to invest in NAYA Biosciences,.
Net Income |
|
NAYA | Select Account or Indicator |
Please note, the presentation of NAYA Biosciences,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NAYA Biosciences,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NAYA Biosciences,'s management manipulating its earnings.
NAYA Biosciences, Stock Summary
NAYA Biosciences, competes with Lincoln Educational, SNDL, Keurig Dr, Afya, and Safety Shot. NAYA Biosciences, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Medical Devices |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 44984F302 44984F401 44984F104 44984F203 |
| Older Symbol | INVO |
| Location | Florida; U.S.A |
| Business Address | 5582 Broadcast Court, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | nayabiosciences.com |
| Phone | 978 878 9505 |
NAYA Biosciences, Key Financial Ratios
| Price To Sales | 0.18 X | ||||
| Revenue | 3.02 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.03 M) | ||||
| Book Value Per Share | (3.91) X |
NAYA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NAYA Biosciences,'s current stock value. Our valuation model uses many indicators to compare NAYA Biosciences, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NAYA Biosciences, competition to find correlations between indicators driving NAYA Biosciences,'s intrinsic value. More Info.NAYA Biosciences, is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 0.32 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for NAYA Biosciences, is roughly 3.14 . As of February 27, 2025, Common Stock Shares Outstanding is expected to decline to about 2.4 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NAYA Biosciences,'s earnings, one of the primary drivers of an investment's value.NAYA Biosciences, Systematic Risk
NAYA Biosciences,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NAYA Biosciences, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on NAYA Biosciences, correlated with the market. If Beta is less than 0 NAYA Biosciences, generally moves in the opposite direction as compared to the market. If NAYA Biosciences, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NAYA Biosciences, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NAYA Biosciences, is generally in the same direction as the market. If Beta > 1 NAYA Biosciences, moves generally in the same direction as, but more than the movement of the benchmark.
About NAYA Biosciences, Financials
What exactly are NAYA Biosciences, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include NAYA Biosciences,'s income statement, its balance sheet, and the statement of cash flows. Potential NAYA Biosciences, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although NAYA Biosciences, investors may use each financial statement separately, they are all related. The changes in NAYA Biosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NAYA Biosciences,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.NAYA Biosciences, Thematic Clasifications
NAYA Biosciences, is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Medical Equipment | View |
Today, most investors in NAYA Biosciences, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NAYA Biosciences,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NAYA Biosciences, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
NAYA Biosciences, February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NAYA Biosciences, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NAYA Biosciences,. We use our internally-developed statistical techniques to arrive at the intrinsic value of NAYA Biosciences, based on widely used predictive technical indicators. In general, we focus on analyzing NAYA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NAYA Biosciences,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 52.37 | |||
| Value At Risk | (8.75) | |||
| Potential Upside | 10.34 |
Complementary Tools for NAYA Stock analysis
When running NAYA Biosciences,'s price analysis, check to measure NAYA Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NAYA Biosciences, is operating at the current time. Most of NAYA Biosciences,'s value examination focuses on studying past and present price action to predict the probability of NAYA Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NAYA Biosciences,'s price. Additionally, you may evaluate how the addition of NAYA Biosciences, to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |